Biotech

All Articles

I &amp I biotech Triveni elevates $115M for preclinical antibodies

.Triveni Bio has actually roped in $115 thousand in series B funds to advance preclinical antibody p...

IGM pivots coming from cancer cells to autoimmune, shocking C-suite

.IGM Biosciences ended in 2013 laying off workers and enhancing its cancer pipe. Currently, the prov...

Shattuck centers CD47 course over weak efficiency information, gives up 40% of personnel and sheds Ono handle

.Shattuck Labs has actually pounded an additional nail in to the coffin of CD47. After finding a "sm...

BioMarin goes Backpacking, striking RNA take care of biotech

.BioMarin is actually adding combustion to the R&ampD fire, attacking a match along with CAMP4 Thera...

Cash- strapped Gritstone starts look for critical choices as cancer injection data underwhelm

.Gritstone bio has actually produced bankers to look into "prospective value-maximizing approaches" ...

Kailera launches with $400M series A, 4 Chinese weight problems medicines

.Kailera Therapies has actually launched right into the more and more packed obesity space with a co...

Metsera coordinate with Amneal to lock down GLP-1 source

.With early stage 1 records now out in the wild, metabolic disease ensemble Metsera is actually thro...

Rivus posts data to back up muscle-sparing excessive weight drug claims

.Rivus Pharmaceuticals has actually unveiled the records behind its stage 2 excessive weight win in ...

BMS pays out $110M to form T-cell therapy contract, helping Best acquire opportunity to improve prioritized pipeline

.Bristol Myers Squibb is spending Main Medication $110 thousand ahead of time to develop reagents fo...

Generate increases another $1B-plus Major Pharma relationship

.Novartis has actually inked a deal potentially worth much more than $1 billion with Flagship-founde...